Recommended vaccine |
Dose of the vaccine |
Route of administration |
Time of administration |
In-hospital protocol |
|
|
|
Pneumococcal 13-valent conjugate (PCV13: Prevnar 13) |
0.5 mL |
IM |
On the day of discharge or day 14, whichever comes first |
Haemophilus influenza type b vaccine (Hib: ActHIB) |
0.5 mL |
IM |
On the day of discharge or day 14, whichever comes first |
Meningococcal vaccine (Menactra) |
0.5 mL |
IM |
On the day of discharge or day 14, whichever comes first |
Meningococcal serogroup B (Bexsero) |
0.5 mL |
IM |
On the day of discharge or day 14, whichever comes first |
Short-term follow-up |
|
|
|
Pneumococcal polysaccharide (PPSV23: Pneumovax 23) |
0.5 mL |
IM |
Two months after the initial vaccination |
Meningococcal vaccine |
0.5 mL |
IM |
Two months after the initial vaccination |
Meningococcal serogroup B |
0.5 mL |
IM |
Two months after the initial vaccination |
Long-term follow-up |
|
|
|
Pneumococcal polysaccharide |
0.5 mL |
IM |
5 years after the first dose |
Meningococcal vaccine |
0.5 mL |
IM |
Every 5 years |
Seasonal influenza vaccine |
- |
- |
Annually |